Abstract
Helicases are enzymes that unwind DNA-DNA and RNA-DNA duplexes play important roles in many DNA metabolic activities like replication, transcription, recombination and repair. The molecular link between helicases and genomic stability has become stronger by recent studies indicating that the genes responsible for certain human degenerative disorders such as Werner syndrome (WS), Bloom syndrome (BS) and Rothmund-Thomson syndrome (RTS) encode for helicase domain containing proteins (HDPs) homologous to bacterial RecQ super family of helicases. The patients suffering from these disorders show many signs that are suggestive of accelerated aging at an early adulthood. Some of the features include atrophy of the skin, graying of the hair, cataracts, diabetes and osteoporosis. Additionally, symptoms of accelerated aging and genomic instability have also been noticed in xeroderma pigmentosum (XP) and Cockayne syndrome (complementation group B) patients. The gene products of XP complementation groups B and D are helicases and they play dual roles both in nucleotide excision repair and RNA polymerase II transcription. The CSB protein with a remarkably conserved helicase domain is homologous to yeast SWI/SNF family of proteins that have regulatory roles in transcription, chromosome stability and DNA repair. Although genomic instability is a common feature of helicase disorders, elucidation of precise biological function(s) of helicases is critical for defining the molecular basis for diverse clinical symptoms of these patients. Recent studies have characterized the preferred DNA substrates for RecQ helicases and also identified the interaction of HDPs with a number of proteins involved in DNA replication, transcription, recombination and repair. These interactions have given great insights into functional complexities of helicases. This review deals with our current knowledge on the diverse biological functions of HDPs and their collective role in the maintenance of genomic stability.
Current Genomics
Title: Helicase Domain Containing Proteins in Human Disorders
Volume: 2 Issue: 4
Author(s): Adayabalam S. Balajee and Colette ApRhys
Affiliation:
Abstract: Helicases are enzymes that unwind DNA-DNA and RNA-DNA duplexes play important roles in many DNA metabolic activities like replication, transcription, recombination and repair. The molecular link between helicases and genomic stability has become stronger by recent studies indicating that the genes responsible for certain human degenerative disorders such as Werner syndrome (WS), Bloom syndrome (BS) and Rothmund-Thomson syndrome (RTS) encode for helicase domain containing proteins (HDPs) homologous to bacterial RecQ super family of helicases. The patients suffering from these disorders show many signs that are suggestive of accelerated aging at an early adulthood. Some of the features include atrophy of the skin, graying of the hair, cataracts, diabetes and osteoporosis. Additionally, symptoms of accelerated aging and genomic instability have also been noticed in xeroderma pigmentosum (XP) and Cockayne syndrome (complementation group B) patients. The gene products of XP complementation groups B and D are helicases and they play dual roles both in nucleotide excision repair and RNA polymerase II transcription. The CSB protein with a remarkably conserved helicase domain is homologous to yeast SWI/SNF family of proteins that have regulatory roles in transcription, chromosome stability and DNA repair. Although genomic instability is a common feature of helicase disorders, elucidation of precise biological function(s) of helicases is critical for defining the molecular basis for diverse clinical symptoms of these patients. Recent studies have characterized the preferred DNA substrates for RecQ helicases and also identified the interaction of HDPs with a number of proteins involved in DNA replication, transcription, recombination and repair. These interactions have given great insights into functional complexities of helicases. This review deals with our current knowledge on the diverse biological functions of HDPs and their collective role in the maintenance of genomic stability.
Export Options
About this article
Cite this article as:
Balajee S. Adayabalam and ApRhys Colette, Helicase Domain Containing Proteins in Human Disorders, Current Genomics 2001; 2 (4) . https://dx.doi.org/10.2174/1389202013350742
DOI https://dx.doi.org/10.2174/1389202013350742 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Can PPARγ Ligands Be Used in Cancer Therapy?
Current Medicinal Chemistry - Anti-Cancer Agents Chromatin Remodeling Agents for Cancer Therapy
Reviews on Recent Clinical Trials Micro/Nanoparticle Design and Fabrication for Pharmaceutical Drug Preparation and Delivery Applications
Current Drug Therapy RANKL/RANK/OPG: Key Therapeutic Target in Bone Oncology
Current Drug Discovery Technologies Suppression of NF-κB Activation By Gentian Violet Promotes Osteoblastogenesis and Suppresses Osteoclastogenesis
Current Molecular Medicine A New Investigational Perspective for Purines Against Glioblastoma Invasiveness
Current Drug Targets Tumoural Expression of Connective Tissue Growth Factor (CTGF) Impacts on Survival in Patients Diagnosed with Hepatocellular Carcinoma (HCC)
Current Cancer Drug Targets Role of Advanced Glycation End Products (AGEs) in Osteoporosis in Diabetes
Current Drug Targets Focus on MicroRNAs as Biomarker in Pediatric Diseases
Current Pharmaceutical Design Tumor Protein p63/microRNA Network in Epithelial Cancer Cells
Current Genomics Time Dependent Distribution of MicroRNA 144 after Intravenous Delivery
MicroRNA Radionuclides Used in Nuclear Medicine Therapy – From Production to Dosimetry
Current Medical Imaging Advances in Nanocarriers for Anticancer Drugs Delivery
Current Medicinal Chemistry Dietary Phytochemicals in Chemoprevention of Cancer: An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Aerosol Delivery in the Treatment of Lung Cancer
Current Cancer Drug Targets Melatonin, Autophagy and Intestinal Bowel Disease
Current Pharmaceutical Design Recent Results on A-Ring Modification of 1α,25-Dihydroxyvitamin D3: Design and Synthesis of VDR-Agonists and Antagonists with High Biological Activity
Current Topics in Medicinal Chemistry Oxidation Inhibits Iron-Induced Blood Coagulation
Current Drug Targets MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs
Current Drug Targets Stimuli Responsive Nanoparticles for Controlled Anti-cancer Drug Release
Current Medicinal Chemistry